Archive — US — techcrunch
Scimplify raises $40M to help manufacturers access specialty chemicals
Scimplify, an Indian startup assisting pharmaceutical and agriculture firms in sourcing specialty chemicals, has raised $40M in a Series B funding round to expand its operations and target new markets, particularly in the U.S. Valued at $150M post-money, the company aims to connect manufacturers with specialized chemical producers amidst geopolitical shifts reducing reliance on Chinese suppliers.
Key points
- Scimplify raised $40M in Series B funding, co-led by Accel and Bertelsmann Investments.
- Valuation after funding is approximately $150M, allowing for geographic and product expansion.
- Focus on connecting businesses to specialty chemical producers globally, addressing supply chain issues.
- Specialty chemicals are crucial across industries, but access is challenging due to geopolitical tensions, leading companies to seek alternatives to Chinese suppliers.
- The platform, ATOMS, includes listings from over 5,000 factories across 10 countries, serving mainly pharmaceutical and agricultural sectors.
- Scimplify plans to enhance R&D, expand global presence including establishing U.S. offices, and potentially acquire chemical factories to diversify offerings.
Why it matters
- The shift towards diversifying supply chains reflects broader trends in global manufacturing, particularly post-COVID-19.
- Increasing geopolitical tensions are driving changes in sourcing strategies in multiple industries.
- The growth of startups like Scimplify aligns with the trend of digital procurement solutions adapting to industry needs.
Scimplify's fundraising and strategic focus on connecting manufacturers to specialty chemical suppliers reflect the evolving landscape of global supply chains and the increasing demand for agile sourcing options amidst geopolitical uncertainties.